Stay updated on BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Version updated from v3.3.3 to v3.3.4 on the page.
    Difference
    0.0%
    Check dated 2026-01-15T04:31:18.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now lists study locations by state (Arkansas, California, Florida, Kentucky, Louisiana, Missouri, Nevada, New Jersey, Ohio, South Carolina, Texas) and shows an updated revision tag (v3.3.3). The HHS Vulnerability Disclosure link was removed.
    Difference
    1%
    Check dated 2025-12-24T11:52:22.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Footer revision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-25T14:50:46.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The notice regarding government funding and operating status was removed from the page, a non-critical informational banner. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T07:36:04.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected on the Study Details page for NCT03824405; the core information remains unchanged.
    Difference
    0.4%
    Check dated 2025-10-27T21:05:53.000Z thumbnail image
  8. Check
    105 days ago
    Change Detected
    Summary
    Major change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).
    Difference
    3%
    Check dated 2025-10-06T08:25:30.000Z thumbnail image

Stay in the know with updates to BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial page.